PLXP

PLX PHARMA INC

1 day chart

About PLXP

PLx Pharma Inc. is a commercial-stage drug delivery platform technology company, which is focused on its clinically validated and patent-protected PLxGuard technology. The Company has two commercialized products, VAZALORE 81 milligram (mg) and VAZALORE 325 mg, which are liquid-filled aspirin capsules for over the counter (OTC) distribution. The Company markets VAZALORE to the healthcare professional and the consumer through several sales and marketing channels. Its product pipeline also includes other oral NSAIDs using the PLxGuard drug delivery platform, including PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, for pain and inflammation in Phase I clinical stage. PLxGuard drug delivery platform employs a pH-dependent release mechanism that relies on association of lipidic excipients with APIs for targeted release in the GI tract.

Buy US stocks in Australia starting with PLXP. Open an account and start investing today!

Market Capitalisation

$3.79M

Price-earnings ratio

Dividend yield

0.00%

Volume

245.5K

High today

$0.17

Low today

$0.13

Open price

$0.16

52-week high

$4.43

52-week low

$0.12

PLXP FAQs

How much is one share of PLX PHARMA INC?

One share of PLX PHARMA INC is valued at $0.14.

What is the ticker symbol for PLX PHARMA INC?

The ticker symbol for PLX PHARMA INC is PLXP.

How do I buy PLXP shares in Australia?

To buy PLXP stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in PLXP

What is the 52-week high for PLX PHARMA INC stock?

The PLX PHARMA INC 52-week high stock price is $4.43.

What is the 52-week low for PLX PHARMA INC stock?

The PLX PHARMA INC 52-week low stock price is $0.12.

What is the market capitalisation of PLX PHARMA INC PLXP?

As of 02/04/2023 PLX PHARMA INC has a market cap of $3.8M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.